How I Treat Cervical cancer in 2026: OncoDaily Summit
NVIDIA and Eli Lilly Launch $1B AI Co-Innovation Lab to Reinvent Drug Discovery
Monica Bertagnolli is Appointed President of the National Academy of Medicine
Children's Tumor Foundation Welcomes John Puziss as Chief Scientific and Impact Officer
How Remote Therapeutic Monitoring Is Transforming Oncology Care: Inside Relay RTM’s Done-For-You Model
Call for Papers: Special Series on Cancer in Central Asia in 2026
Vivek Subbiah: Rethinking Cancer of Unknown Primary in the Precision Oncology Era
Pat Soon-Shiong Announces 15-Month Ongoing Complete Remission With Chemo-Free CD19 CAR-NK Cell Therapy
The ESMO Preceptorship on Breast Cancer 2026: Milan is a two-day educational course that provides oncologists with a thorough understanding of breast cancer management, covering topics from diagnosis to treatment, based on current standards of care in a multidisciplinary setting. The preceptorship will take place from January 16–17, 2026, in Milan, Italy. The course is […]
The ESMO Advanced Course on CDK4/6 Inhibitors in Breast Cancer Management 2026 is an intensive, single-day educational symposium scheduled for January 24, 2026, in Jeddah, Saudi Arabia. Organized by the European Society for Medical Oncology (ESMO), this event is designed as a closed course specifically for invited medical oncologists and oncology fellows from the Middle […]
The ESMO Guidelines: Real World Cases - Webinar Series: Colorectal Cancer 2026 is a live virtual event focused on discussing real-world clinical cases and applying ESMO guidelines to the management of colorectal cancer. This webinar is scheduled to take place virtually on January 28, 2026, at 18:30 CET (Central European Time). Register.
The ESMO in Focus Immuno-Oncology Bulgaria 2026 is a licensed scientific conference organized by the Bulgarian Scientific Society for Immuno-Oncology (BSIO) in collaboration with the European Society for Medical Oncology (ESMO). Scheduled for January 31, 2026, in Sofia, the meeting serves as a regional forum to disseminate the latest clinical data and therapeutic breakthroughs presented […]
The ESMO Deep Dive: Genitourinary Cancers: Multimodal Therapy in MIBC: From Established Standard to Future Directions 2026 is a technical scientific webinar focused on the evolving treatment landscape of muscle-invasive bladder cancer (MIBC). Scheduled for February 4, 2026, this virtual symposium addresses the clinical challenges of MIBC, which is characterized by high morbidity and mortality. […]
The ESMO Preceptorship on Cervical Cancer 2026: Cape Town is a two-day educational course focusing on providing oncologists with a thorough understanding of cervical cancer management, including screening, prevention, diagnosis, and the standard of care for early, locally advanced, recurrent, and metastatic disease. The event is scheduled for February 5–6, 2026, in Cape Town, South […]
The ESMO Summit Africa 2026 is a three-day educational event focused on delivering a summary and contextual review of the most significant cancer treatment advances presented at the previous ESMO annual Congress, tailored specifically for the oncology community in Africa. Scheduled to take place in Cape Town, South Africa, from 6 to 8 February 2026, […]
The Real World Data and Digital Oncology webinar, EBAI Framework: Evaluating AI-Based Biomarkers in Oncology 2026, is a virtual event that focuses on the practical application of the ESMO Basic Requirements for AI-based Biomarkers in Oncology (EBAI) framework. The live broadcast date is 11 February 2026 at 18:30 CET. This session will explore how emerging […]
ESMO Therapeutic Landscapes: Toxicity of Multispecific Antibodies and Immune-Cell Engagers 2026 is a specialized technical webinar scheduled for February 18, 2026, focused on the safety profiles and clinical management of next-generation biologics. Chaired by Elena Garralda, the program features expert discussions on the molecular mechanisms of on-target/off-tumor effects and evaluates emerging mitigation strategies to optimize […]
The ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2026: Lugano is a two-day educational course focusing on the management of metastatic bladder and kidney cancer, providing oncologists with a thorough understanding of current standards of care, molecular pathology, and novel treatment targets. The preceptorship will take place on February 18–19, 2026, in Lugano, Switzerland, […]
The ESMO Guidelines: Real World Cases - Webinar Series: Gastroesophageal Cancer 2026 is a virtual event designed to help medical professionals apply the latest ESMO Clinical Practice Guidelines to the complex management of gastroesophageal cancers using real-world clinical cases. The webinar will be broadcast live virtually on February 25, 2026, at 18:30 CET. The discussion […]
The ESMO Deep Dive: Genitourinary Cancers: Beyond Cure: Optimizing Medical Care in Metastatic Bladder Cancer 2026 is a specialized scientific webinar designed to provide an in-depth clinical analysis of the treatment landscape for metastatic urothelial carcinoma (mUC). Scheduled for March 4, 2026, this virtual session focuses on the technical challenges of managing advanced disease where […]
The ESMO Advanced Course on Precision Medicine for Patients with HR+ HER2- Advanced Breast Cancer: Testing, Selecting, Treating 2026: Zurich is a two-day course for experienced oncologists and specialists, focusing on using precision medicine to manage patients with HR-positive, HER2-negative metastatic breast cancer. The event is scheduled to take place on March 4–5, 2026, in […]
The ESMO Advanced Course on Management of Patients with Localised Bladder Cancer: State-of-the-Art Therapeutic Strategies and Ongoing Research 2026: Zurich is an intensive educational program designed to provide medical oncologists with a comprehensive update on state-of-the-art therapeutic strategies and ongoing research. Scheduled for March 6–7, 2026, in Zurich, Switzerland, the course focuses on multidisciplinary care, […]
The ESMO - The Christie Preceptorship on Lung Cancer 2026: Manchester will be held from March 11-13, 2026, in Manchester, United Kingdom. The application deadline is January 21, 2026, at 23:59 CET, and the course is accredited for 16 ESMO-MORA category 1 points. The learning objectives cover the full spectrum of thoracic oncology, from screening […]
The ESMO Sarcoma and Rare Cancers Congress 2026 will take place from 12–14 March in Lugano, Switzerland, offering a premier platform for experts to share cutting-edge research and innovative treatment approaches in rare solid tumours. The congress will discuss the latest developments in diagnosis, treatment, molecular biology, and classification of sarcomas and other rare cancers. […]
